Clinical Review

Clinical Review

Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non–Small Cell Lung Cancer: A Meta-analysis

This meta-analysis showed that mutant epidermal growth factor receptor–tyrosine kinase inhibitors have an incidence of adverse effects that is...

Pages